Skip to content
Subscriber Only

J&J Recalls Some of Schizophrenia Drug After Mold Found

Johnson & Johnson is recalling 5,000 vials of its Risperdal Consta, a long-acting drug for patients with schizophrenia, after testing found the medicine was no longer sterile.

Routine analysis showed one lot of the injected drug was contaminated with alternaria alternata, a common mold found in the environment, said Robyn Reed Frenze, a spokeswoman for the New Brunswick, New Jersey-based company’s Janssen unit. There haven’t been any reports of complications among patients who received the medicine, though injection site reactions are possible, she said.